Kimberly-Clark (KMB)
Maker of Huggies diapers, Kleenex tissues, Kotex feminine care, and Depend incontinence products.
$97.83
vs last close−1.08 (−1.09%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,132 | 4,970 | 5,149 | 4,231 | 4,144 | 4,928 | 4,840 | 4,163 | 4,133 | 4,080 | 4,163 | 4,189 |
| Cost of revenue | 3,294 | 3,233 | 3,238 | 2,637 | 2,580 | 3,253 | 3,107 | 2,707 | 2,657 | 2,615 | 2,629 | 2,586 |
| Gross profit | 1,838 | 1,737 | 1,911 | 1,594 | 1,564 | 1,675 | 1,733 | 1,456 | 1,476 | 1,465 | 1,534 | 1,603 |
| 1,064 | 1,067 | 1,058 | 1,055 | 538 | 1,127 | 964 | 864 | 855 | 958 | 1,059 | 1,155 | |
| Research & development | 0 | 312 | 0 | 0 | 0 | 338 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general & administrative | 1,029 | 993 | 1,039 | 967 | 1,006 | 1,109 | 941 | 863 | 855 | 955 | 920 | 1,004 |
| Other expenses | 35 | −238 | 19 | 88 | −468 | −320 | 23 | 1 | 0 | 3 | 139 | 151 |
| Operating income | 774 | 670 | 853 | 539 | 1,026 | 548 | 769 | 592 | 621 | 507 | 475 | 448 |
| −76 | −56 | −72 | −15 | −16 | −25 | −31 | −79 | −29 | −71 | 210 | 124 | |
| Interest income | 18 | 32 | 10 | 9 | 18 | 11 | 7 | 5 | 6 | 6 | 5 | 4 |
| Interest expense | 74 | 70 | 67 | 72 | 67 | 64 | 64 | 67 | 65 | 60 | 58 | 53 |
| Other non-operating income | 2 | −14 | 5 | 6 | −3 | 5 | 11 | 12 | −36 | 11 | −210 | −177 |
| Income before tax | 698 | 614 | 781 | 524 | 1,010 | 523 | 738 | 513 | 592 | 436 | 685 | 572 |
| Income tax expense | 157 | 155 | 123 | 60 | 187 | 71 | 165 | 69 | 248 | 45 | 164 | 217 |
| Net income from continuing operations | 541 | 459 | 658 | 464 | 823 | 452 | 573 | 444 | 344 | 391 | 521 | 355 |
| Discontinued operations | 0 | 0 | 0 | 89 | 0 | 0 | 0 | 68 | 110 | 119 | 101 | −60 |
| Other adjustments | 50 | 53 | 0 | 0 | 92 | 0 | 0 | 0 | 0 | 0 | 53 | 55 |
| Net income | 587 | 509 | 647 | 544 | 907 | 447 | 567 | 509 | 446 | 499 | 665 | 345 |
| EPS, basic | $1.74 | $1.51 | $1.92 | $1.61 | $2.70 | $1.34 | $1.71 | $1.53 | $1.34 | $1.50 | $2.00 | $1.04 |
| EPS, diluted | $1.73 | $1.50 | $1.91 | $1.61 | $2.69 | $1.34 | $1.70 | $1.53 | $1.34 | $1.50 | $2.00 | $1.04 |
| Weighted average shares, basic | 338 | 337 | 337 | 337 | 336 | 334 | 332 | 332 | 332 | 333 | 332 | 333 |
| Weighted average shares, diluted | 339 | 339 | 338 | 338 | 337 | 334 | 333 | 333 | 333 | 333 | 333 | 333 |
| EBITDA | 961 | 871 | 1,033 | 721 | 1,220 | 760 | 976 | 802 | 833 | 685 | 743 | 792 |
| Depreciation & amortization | 189 | 187 | 185 | 188 | 191 | 217 | 218 | 222 | 176 | 189 | 58 | 167 |
| EBIT | 772 | 684 | 848 | 533 | 1,029 | 543 | 758 | 580 | 657 | 496 | 685 | 625 |
